Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma

Jay P. Reddy, Mike Hernandez, Jillian R. Gunther, Bouthaina S. Dabaja, Geoffrey V. Martin, Wen Jiang, Mani Akhtari, Pamela K. Allen, Bradley J. Atkinson, Grace L. Smith, Chelsea C. Pinnix, Sarah A. Milgrom, Zeinab Abou Yehia, Eleanor M. Osborne, Yasuhiro Oki, Hun Lee, Fredrick Hagemeister, Michelle A. Fanale

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences